ACADIA Pharmaceuticals (ACAD) Earnings Date & Reports

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ACAD is expected to report earnings to rise 207.50% to 6 cents per share on August 11

ACADIA Pharmaceuticals ACAD Stock Earnings Reports

Q2'26

Est.

$0.06

Q1'26

Missed

by $0.03

Q4'25

Beat

by $1.46

Q3'25

Beat

by $0.28

Q2'25

Beat

by $0.02

The last earnings report on May 06 showed earnings per share of 1 cents, missing the estimate of 5 cents. With 306.38K shares outstanding, the current market capitalization sits at 3.78B.

View a ticker or compare two or three

Compare

Swing Trader for Mid Caps: Comprehensive Intrinsic Sentinel, 60 min, (FA)Swing Trader for Mid Caps: Comprehensive Intrinsic Sentinel, 60 min, (FA)

Annualized Return+21%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

ACAD

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement